The FDA has approved the first rapid-acting biosimilar insulin product for glycemic control in people with diabetes. Merilog ...
First-ever rapid-acting insulin. This approval extends to a 3-milliliter single-patient-use prefilled pen and a 10-milliliter ...
Putting pregnant women who develop diabetes on a reduced calorie diet could help them avoid the need for insulin injections ...
Between 2018 and 2024, China has launched 188 domestically developed innovative drugs – nearly double the number from the ...
The FDA approved insulin-aspart-szjj (Merilog) as the first rapid-acting insulin biosimilar product to treat adults and ...
A human-derived, ultra-long-acting GLP-1 injection independently researched and developed by Innogen, a Shanghai-based ...
MANILA, Philippines — Being diagnosed with a life-long condition like Type 1 Diabetes can cause fear for the kid and his ...
Mariposa California's original daily updated online newspaper is the premier site for news and information on Yosemite, ...
Sanofi's Merilog wins FDA approval as the first rapid-acting insulin biosimilar to Novolog, offering a new option for diabetes management.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback